Now showing items 1-1 of 1
Efficacy and Safety of an Octreotide Implant in the Treatment of Patients With Acromegaly
(Endocrine Society, 2013-10)
Context: Acromegaly is caused by excessive GH secretion and IGF-I overproduction. The goals of treatment are to reduce GH and IGF-I values to normal and relieve the associated symptoms. Objective: The purpose of this ...